Evidence map›Paper›PMID 33248214›Full record

ArticleThe ocular surface2021

Saturation of cholesteryl esters produced by human meibomian gland epithelial cells after treatment with rosiglitazone.

Jillian F Ziemanski, Landon Wilson, Stephen Barnes, Kelly K Nichols

Open access · greenAbstract read
In one paragraph

Article in The ocular surface, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. A New Organotypic 3D Slice Culture ofInternational journal of molecular sciences · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jillian F ZiemanskiUniversity of Alabama at Birmingham, School of Optometry, Department of Optometry and Vision Science, Birmingham, AL, USA. Electronic address: jfmead@uab.edu.
Landon WilsonUniversity of Alabama at Birmingham, School of Medicine, Department of Pharmacology and Toxicology, Birmingham, AL, USA.
Stephen BarnesUniversity of Alabama at Birmingham, School of Medicine, Department of Pharmacology and Toxicology, Birmingham, AL, USA.
Kelly K NicholsUniversity of Alabama at Birmingham, School of Optometry, Department of Optometry and Vision Science, Birmingham, AL, USA.
University of Alabama at Birmingham · US

Funding

Complement and Dry Eye Disease Associated with Primary Sjogren's SyndromeK23EY028629 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZIEMANSKI, JILLIAN F · 2019 to 2023
$717k
5500 Q-Trap Mass SpectrometerS10RR027822 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2010 to 2010
$469k
NCRR NIH HHS S10 RR027822NEI NIH HHS K23 EY028629
6 · The paper itself

Abstract

purposeThe purpose of this study was to compare the cholesteryl ester (CE) profiles expressed from human meibomian gland epithelial cells (HMGECs) in response to rosiglitazone-induced differentiation to that of normal human meibum.

methodsHMGECs were cultured with rosiglitazone (vehicle control, 20 μM, or 50 μM) and fetal bovine serum (FBS, 2% or 10%) for 2 days or 5 days. Following culture, lipid extracts were processed and analyzed by ESI-MSMS

resultsThere were 34 CEs with carbon number ranging from 14 to 34 detected from HMGECs. Across all conditions, HMGECs provided a CE profile that was 14.0% saturated, 60.6% monounsaturated, and 25.4% polyunsaturated. Culturing with 50 μM rosiglitazone and 2% FBS for 2 days resulted in the greatest number of upregulated saturated and monounsaturated CEs and downregulated polyunsaturated CEs. Five CEs were identified as being the most responsive to 50 μM rosiglitazone: CE 24:1, CE 28:1, CE 26:1, CE 18:1, and CE 22:1.

conclusionAlthough differences in the CE profile exist between meibum and HMGECs, rosiglitazone promotes upregulation of highly expressed meibum-relevant CEs and shifts the saturation level toward a more meibum-like profile. The use of rosiglitazone as a differentiating agent is recommended in HMGEC research, and analysis by ESI-MSMS

Indexed as

Cholesterol EstersMeibomian GlandsEpithelial CellsHumansRosiglitazoneTearsCholesterol EstersRosiglitazoneCholesteryl estersHuman meibomian gland epithelial cellsMass spectrometryMeibomian glandPeroxisome proliferator activator receptor-γ (PPARγ)Rosiglitazone

Identifiers

PMID33248214
PMCPMC8113060
OpenAlexW3107591333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.